Recruiting NA INTERVENTIONAL 1-arm NCT06537960

Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers (TARDITEP)

Intérêt Des Images Tardives Pour le Bilan d'Extensions en TEP-TDM au 18FGD Des Cancers de Vessie Infiltrant le Muscle (TARDITEP)

Sponsor: Hopital Foch

Conditions Bladder Cancer Muscle-Invasive Bladder Carcinoma

Interventions 18FDG PET-CT

Updated 2 times since 2024 Last updated: Nov 18, 2025 Started: Dec 14, 2023 Primary completion: Mar 15, 2027 Completion: Mar 15, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bladder Cancer and Muscle-Invasive Bladder Carcinoma and is currently actively recruiting participants. Hopital Foch leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

2 versions recorded

Dec 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Dec 2025 [monthly]

Recruiting NA

First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital Foch

Data source: Hopital Foch

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suresnes, France